Polymorphisms of KDR Gene Are Associated With Coronary Heart Disease

Journal of the American College of Cardiology

Volumn 50, Issue 8, 2007, Pages 760-767

  Wang, Yibo ^a   Zheng, Yi ^a   Zhang, Weili ^a   Yu, Hui ^a   Lou, Kejia ^a   Zhang, Yu ^a   Qin, Qin ^b   Zhao, Bingrang ^b   Yang, Ying ^c   Hui, Rutai ^a  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b TIANJIN CHEST HOSPITAL   (China)

^c Qingdao FuWai Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LUCIFERASE; VASCULOTROPIN RECEPTOR 2;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BLOOD LEVEL; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; HUMAN; ISCHEMIC HEART DISEASE; LIGAND BINDING; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; POPULATION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; VASCULAR SURGERY;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHINA; CORONARY DISEASE; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MUTATION, MISSENSE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); TRANSCRIPTION, GENETIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 34547849753     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2007.04.074     Document Type: Article

References (38)

1. Choy J.C., Granville D.J., Hunt D.W., and McManus B.M. Endothelial cell apoptosis: biochemical characteristics and potential implications for atherosclerosis. J Mol Cell Cardiol 33 (2001) 1673-1690
2. Gill M., Dias S., Hattori K., et al. Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells. Circ Res 88 (2001) 167-174
3. Naghavi M., Libby P., Falk E., et al. From vulnerable plaque to vulnerable patient: a call for new definition and risk assessment strategies, part I. Circulation 108 (2003) 1664-1672
4. Mutin M., Canavy I., Blann A., Bory M., Sampol J., and Dignat-George F. Direct evidence of endothelial injury in acute myocardial infarction and unstable angina by demonstration of circulating endothelial cells. Blood 93 (1999) 2951-2958
5. Mallat Z., Benamer H., Hugel B., et al. Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation 101 (2000) 841-843
6. Shalaby F., Ho J., Stanford W.L., et al. A requirement for Flk1 in primitive and definitive hematopoiesis and vasculogenesis. Cell 89 (1997) 981-990
7. Fong G.H., Rossant J., Gertsenstein M., and Breitman M.L. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376 (1995) 66-70
8. Shalaby F., Rossant J., Yamaguchi T.P., et al. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376 (1995) 62-66
9. Gerber H.P., McMurtrey A., Kowalski J., et al. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway: requirement for Flk-1/KDR activation. J Biol Chem 273 (1998) 30336-30343
10. Takahashi T., Yamaguchi S., Chida K., and Shibuya M. A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells. EMBO J 20 (2001) 2768-2778
11. Waltenberger J., Claesson-Welsh L., Siegbahn A., Shibuya M., and Heldin C.H. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J Biol Chem 269 (1994) 26988-26995
12. Barger A.C., Beeuwkes III R., Lainey L.L., and Silverman K.J. Hypothesis: vasa vasorum and neovascularization of human coronary arteries. A possible role in the pathophysiology of atherosclerosis. N Engl J Med 310 (1984) 175-177
13. Moulton K.S. Plaque angiogenesis: its functions and regulation. Cold Spring Harb Symp Quant Biol 67 (2002) 471-482
14. Asahara T., Murohara T., Sullivan A., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275 (1997) 964-967
15. Lin Y., Weisdorf D.J., Solovey A., and Hebbel R.P. Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 105 (2000) 71-77
16. Walter D.H., Rittig K., Bahlmann F.H., et al. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 105 (2002) 3017-3024
17. Hill J.M., Zalos G., Halcox J.P., et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348 (2003) 593-600
18. Takahashi T., Kalka C., Masuda H., et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 5 (1999) 434-438
19. Griese D.P., Ehsan A., Melo L.G., et al. Isolation and transplantation of autologous circulating endothelial cells into denuded vessels and prosthetic grafts: implications for cell-based vascular therapy. Circulation 108 (2003) 2710-2715
20. Dimmeler S., Aicher A., Vasa M., et al. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest 108 (2001) 391-397
21. Rehman J., Li J., Parvathaneni L., et al. Exercise acutely increases circulating endothelial progenitor cells and monocyte-/macrophage-derived angiogenic cells. J Am Coll Cardiol 43 (2004) 2314-2318
22. Strehlow K., Werner N., Berweiler J., et al. Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation. Circulation 107 (2003) 3059-3065
23. Werner N., Priller J., Laufs U., et al. Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation: effect of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition. Arterioscler Thromb Vasc Biol 22 (2002) 1567-1572
24. O'Donnell C.J., Lindpaintner K., Larson M.G., et al. Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study. Circulation 97 (1998) 1766-1772
25. Weisz A., Koren B., Cohen T., et al. Increased vascular endothelial growth factor 165 binding to kinase insert domain-containing receptor after infection of human endothelial cells by recombinant adenovirus encoding the Vegf(165) gene. Circulation 103 (2001) 1887-1892
26. Wang Y., Zhang W., Zhang Y., et al. VKORC1 haplotypes are associated with arterial vascular diseases (stroke, coronary heart disease, and aortic dissection). Circulation 113 (2006) 1615-1621
27. Matsumoto T., and Claesson-Welsh L. VEGF receptor signal transduction. Sci STKE 112 (2001) RE21
28. Tenaglia A.N., Peters K.G., Sketch Jr. M.H., and Annex B.H. Neovascularization in atherectomy specimens from patients with unstable angina: implications for pathogenesis of unstable angina. Am Heart J 135 (1998) 10-14
29. Schwartz S.M., and Benditt E.P. Clustering of replicating cells in aortic endothelium. Proc Natl Acad Sci U S A 73 (1976) 651-653
30. Op den Buijs J., Musters M., Verrips T., Post J.A., Braam B., and van Riel N. Mathematical modeling of vascular endothelial layer maintenance: the role of endothelial cell division, progenitor cell homing, and telomere shortening. Am J Physiol Heart Circ Physiol 287 (2004) H2651-H2658
31. Peichev M., Naiyer A.J., Pereira D., et al. Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors. Blood 95 (2000) 952-958
32. Hristov M., and Weber C. Endothelial progenitor cells: characterization, pathophysiology, and possible clinical relevance. J Cell Mol Med 8 (2004) 498-508
33. Kuzuya M., Ramos M.A., Kanda S., et al. VEGF protects against oxidized LDL toxicity to endothelial cells by an intracellular glutathione-dependent mechanism through the KDR receptor. Arterioscler Thromb Vasc Biol 21 (2001) 765-770
34. Kariyazono H., Ohno T., Khajoee V., et al. Association of vascular endothelial growth factor (VEGF) and VEGF receptor gene polymorphisms with coronary artery lesions of Kawasaki disease. Pediatr Res 56 (2004) 953-959
35. The International HapMap Consortium. The International HapMap Project. Nature 426 (2003) 789-796
36. Vasa M., Fichtlscherer S., Aicher A., et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 89 (2001) E1-E7
37. Werner N., Kosiol S., Schiegl T., et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353 (2005) 999-1007
38. Schmidt-Lucke C., Rossig L., Fichtlscherer S., et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 111 (2005) 2981-2987